High blood levels of TMAO predicts chronic kidney disease risk in future

New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time.

China’s NMPA approves Zai Lab-argenx’s efgartigimod alfa

Beyond gMG, efgartigimod SC is under evaluation for the treatment of additional autoimmune disorders. Credit: Gorodenkoff/Shutterstock. China’s National Medical Products Administration (NMPA) has approved for

July 17, 2024

Medicinal Mushroom Market Anticipated to Reach USD 62.0 Bn by 2032 with 8.7% CAGR | Analysis by Marketresearch.biz | Psychedelic Invest

Rising demand for medicinal mushrooms, like reishi, cordyceps, lion’s mane, and chaga, is fueled by their delightful taste and health benefits. They’re becoming popular ingredients

October 9, 2023

Cybin – The Most Explosive Potential Pharmaceutical Company After LLY and NVO – Biotech Investments

EQS Newswire / 19/06/2024 / 21:51 EST/EDT In the past, many notable figures have suffered from depression, with some even taking their own lives, earning

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.